drugset / Trial / NCT03403049
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
Phase 1
Completed
14 enrolled
Montefiore Medical Center
Shanghai Proton and Heavy Ion Center · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a phase I trial to determine the maximum tolerated dose of carbon ion radiotherapy for the treatment of locally advanced, unresectable, pancreatic cancer.
Timeline
- Start
- 2016-04-01
- Primary completion
- 2019-07-09
- Completion
- 2019-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Capecitabine | Small molecule | — | — |
| Background | Cisplatin | Other / unclassified | — | — |
| Background | Erlotinib | Small molecule | — | — |
| Background | Gemcitabine | Small molecule | — | — |